Shareholding disclosure

Vifor Pharma AG

Collectively declared rate

25.48%

Threshold

Crossed upwards

Timeline

Published

06.06.2015

Transaction

02.06.2015

Transfer date

02.06.2015

Voting rights breakdown

Voting rights acquired25.48%
Voting rights sold0%
Below threshold0%

Declared beneficial owners · 2

A single, collectively filed disclosure: the voting-rights rate applies to the whole group, not to each person.

Notice details

CategoryGroup of shareholders
ExchangeXSWX

Notification ID

TBF6400026

Beneficial owner

Stefano Pessina

Declared address

Stefano Pessina, 98000 Monaco

Name change of the direct holder and of certain indirect holders of shares. The direct holder of the shares, Alliance Boots Investment 2 GmbH, changed its name to Sprint Investments 2 GmbH. Other entities of the Sprint Acquisitions Holdings Limited group (formerly AB Acquisitions Holdings Limited) also changed their names to include the component "Sprint". No other changes in the direct holder of the shares or in the indirect ownership structure occurred. The current ownership structure is as follows: Sprint Investments 2 GmbH is a wholly-owned subsidiary of Sprint Investments 4 Limited, Sedley Place, 4th Floor, 361 Oxford Street, London W1C 2JL, UK. Sprint Investments 4 Limited is a wholly-owned subsidiary of Sprint Acquisitions Holdings Limited, 57/63 Line Wall Road, Gibraltar. The two ultimate beneficial owners Stefano Pessina, 24 Bd du Tenao, 98000 Monaco, Monaco, and Kohlberg Kravis Roberts & Co. L.P., 9 West 57 Street, Suite 4200, New York 10019, USA hold their participation in Galenica AG through Sprint Acquisitions Holdings Limited. The shareholding of the group in Galenica AG (held through Sprint Investments 2 GmbH) remains unchanged (total 1,656,172 shares, of which 1,300,000 (i.e. 20% of the total number of voting rights in Galenica AG) with exercisable voting rights).

These figures aggregate public disclosures. They are not investment advice.

Source: SIX Exchange Regulation

insider24.ch

Never miss a market signal again

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open